Download PDF

Other users also viewed these articles

Economic impact of the use of patiromer in chronic kidney disease or heart failure for the treatment of chronic hyperkalemia in Spain Patricia de Sequera; Ramón Bover; Yoana Ivanova-Markova; Alexandra Ivanova; Almudena González-Domínguez; Marta Valls; Verónica Campos;
Nefrologia (English Version). 2023;43:721-30
Cost-effectiveness of sodium zirconium cyclosilicate for the treatment of hyperkalemia in patients with chronic kidney disease or heart failure in Spain Roberto Alcázar-Arroyo; María G Crespo-Leiro; Jordi Bover; Juan Oliva; Miren Sequera-Mutiozabal; Simona Gradari; Anisia Martínez-López; Blanca López-Chicheri; Neus Vidal-Vilar; Susana Aceituno; Marta Cobo;
Nefrologia (English Version). 2024;44:709-20
Effect of SGLT2 inhibitors on anemia and their possible clinical implications Aleix Cases; Secundino Cigarrán; José Luis Górriz; Julio Nuñez;
Nefrologia (English Version). 2024;44:165-72